Atlas Trials

Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized Approach

Clinical trial NCT02419313 · COMPLETED

Trial details

NCT number
NCT02419313
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ParkinsonTremor
Start date
2012-08-01
Primary completion
2015-09-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.